|
|
|
|
|||||
| Accession | Disease | Description | Year | Source | RNA-Seq | Count | Biomarkers |
| GSE10645 | Prostate Cancer | Focused gene expression microarray of tumors from 596 men with prostate cancer using RNA from archival FFPE tissue | 2008 | Tissue | N | 1192 |
|
| GSE46691 | Prostate Cancer | Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy | 2013 | Tissue | N | 545 |
|
| GSE141551 | Prostate Cancer | Genome-wide gene expression profiles of primary prostate cancer | 2019 | Tissue | N | 503 |
|
| GSE85570 | Prostate Cancer | Inefficient DNA-DSB repair via the homologous recombination pathway in prostate cancer patients with late radiation toxicity | 2016 | Blood | N | 440 |
|
| GSE140440 | Prostate Cancer | Single Cell Analysis Reveals NUPR1 Promotes Docetaxel Resistance in Prostate Cancer | 2019 | Cell line | Y | 324 |
|
| GSE134051 | Prostate Cancer | Differential gene expression analysis by assessing expression variation between tissue specimen of prostate cancer (PCa) and benign prostate hyperplasia (BPH) on a custom expression microarray | 2019 | Tissue | N | 255 |
|
| GSE116918 | Prostate Cancer | Using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy | 2018 | Tissue | N | 248 |
|
| GSE17951 | Prostate Cancer | Gene expression analysis of prostate cancer samples using Affymetrix U133Plus2 array | 2009 | Tissue | N | 154 |
|
| GSE68555 | Prostate Cancer | caArray_becic-00235: Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy | 2015 | Tissue | N | 152 |
|
| GSE72220 | Prostate Cancer | Application of a clinical assay for staging and prognosis of prostate cancer diagnosed in needle core biopsy specimens | 2015 | Tissue | N | 147 |
|
| GSE199596 | Prostate Cancer | Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration Resistant Prostate Cancer | 2022 | Tissue | Y | 121 |
|
| GSE37199 | Prostate Cancer | Blood mRNA expression signatures derived from unsupervised analyses identify prostate cancers with poor outcome | 2012 | Blood | N | 107 |
|
| GSE54460 | Prostate Cancer | RNAseq Analysis of Formalin-Fixed Paraffin-Embedded Prostate Cancer Tissues | 2014 | Tissue | Y | 106 |
|
| GSE6099 | Prostate Cancer | Integrative Molecular Concepts Modeling of Prostate Cancer Progression | 2006 | Tissue | N | 104 |
|
| GSE31189 | Bladder Cancer | Molecular Biomarker Signature for Bladder Cancer Detection | 2011 | Tissue | N | 92 |
|
| GSE30174 | Prostate Cancer | Molecular-genetic correlates of fatigue in cancer patients receiving localized external beam radiation therapy | 2011 | Blood | N | 80 |
|
| GSE25136 | Prostate Cancer | Optimizing molecular signatures for prostate cancer recurrence | 2010 | Tissue | N | 79 |
|
| GSE79915 | Prostate Cancer | Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy | 2016 | Tissue | N | 70 |
|
| GSE85672 | Prostate Cancer | Characterization of an abiraterone ultra-responsive phenotype in castration-resistant prostate cancer patient-derived xenografts | 2016 | Tissue | N | 70 |
|
| GSE134073 | Prostate Cancer | Differential gene expression analysis by assessing transcriptome-wide expression variation between tissue specimen of prostate cancer (PCa) and benign prostate hyperplasia (BPH) | 2019 | Tissue | Y | 64 |
|
| GSE32269 | Prostate Cancer | Expression data for primary localized prostate cancer versus castration-resistant bone metastatic prostate cancer | 2011 | Tissue | N | 55 |
|
| GSE46602 | Prostate Cancer | Expression data from prostate cancer and benign prostate glands | 2013 | Tissue | N | 50 |
|
| GSE111177 | Prostate Cancer | Identification of Transcription Factor Relationships Associated with Androgen Deprivation Therapy Response and Metastatic Progression in Prostate Cancer | 2018 | Tissue | Y | 48 |
|
| GSE55063 | Prostate Cancer | Therapeutic Targeting of BET Bromodomain Proteins in Castration-Resistant Prostate Cancer (microarray) | 2014 | Cell lines | N | 48 |
|
| GSE71781 | Prostate Cancer | Gene expression profiling of the prostate biopsy samples (cancer and adjacent normal tissues) from African American prostate cancer patients | 2014 | Tissue | N | 40 |
|
| GSE64331 | Prostate Cancer | Gene expression profiling of the prostate biopsy samples from African American and European American prostate cancer patients | 2014 | Tissue | N | 35 |
|
| GSE89223 | Prostate Cancer | Novel RNA biomarkers of prostate cancer revealed by RNA-seq analysis of formalin-fixed samples obtained from Russian patients | 2016 | Tissue | Y | 32 |
|
| GSE55055 | Prostate Cancer | RNA profiling from prostate FFPE specimens (Nanostring) | 2014 | Tissue | Y | 24 |
|
| GSE55945 | Prostate Cancer | Gene Expression Profiling of Prostate Benign and Malignant Tissue | 2014 | Tissue | N | 19 |
|
| GSE51005 | Prostate Cancer | Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy | 2013 | Tissue | Y | 12 |
|
| GSE45016 | Prostate Cancer | Expression data from High-grade prostate cancer cells | 2013 | Tissue | N | 11 |
|
| GSE77910 | Prostate Cancer | Gene expression of prostate tumor tissues treated with leuprolide acetate plus ipilimumab | 2016 | Tissue | N | 9 |
|
| GSE137070 | Prostate Cancer | Post-transcriptional gene regulation by microRNA-194 promotes neuroendocrine transdifferentiation in prostate cancer | 2019 | Cell line | Y | 8 |
|